Evidence map›Paper›PMID 31182442›Full record

ArticleBMJ open2019

Evaluation of a prescription support-tool for chronic management of oral antithrombotic combinations in adults using clinical vignettes: protocol of a randomised controlled trial.

Lorene Zerah, Dominique Bonnet-Zamponi, Paul Frappé, Marie Hauguel-Moreau, Yann De Rycke, Anne-Marie Magnier, Eric Pautas, Pierre Charles, Jean-Philippe Collet, Agnes Dechartres and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03630874 (Evaluation of a Prescription Support-tool for Chronic Management of Oral Antithrombotic Combinations in Adults), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03630874 nacompletednot on this map

Evaluation of a Prescription Support-tool for Chronic Management of Oral Antithrombotic Combinations in Adults: Protocol of a Randomized Controlled Trial Using Clinical Vignettes

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2018 to 2019Enrolled478ConditionsAntithrombotics PrescriptionsArmsEvaluate the impact of a prescription support tool
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lorene ZerahINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.ORCID 0000-0002-3474-2200
Dominique Bonnet-ZamponiINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.
Paul FrappéIRMG, Institut de recherche en médecine générale, Paris, France.
Marie Hauguel-MoreauSorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, Département de cardiologie, Paris, France.
Yann De RyckeINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.
Anne-Marie MagnierDépartement de médecine générale, Sorbonne Université, Paris, France.
Eric PautasAP-HP, Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, Département de gériatrie, Sorbonne Université, Paris, France.
Pierre CharlesMédecine Interne, Institut Mutualiste Montsouris, Paris, France.
Jean-Philippe ColletSorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, Département de cardiologie, Paris, France.
Agnes DechartresINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.
Florence TubachINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionImproving the appropriateness of prescriptions of oral antithrombotic (AT) drugs, especially AT combinations, is crucial because these drugs are implicated in bleeding events. We developed a prescription support-tool synthesising guidelines on chronic management of oral AT combinations. Our main objective is to assess the impact of this tool on improving the prescription of oral ATs to comply with guidelines. METHODS AND ANALYSIS: A randomised controlled trial will be conducted among French general practitioners and cardiologists involved in outpatient settings. Physicians will be invited to participate to an online survey by email via physician associations, social networks or word of mouth. They will be randomised to two arms: the experimental arm (access to the prescription support-tool) or the control arm (no prescription support-tool). Then, all participants will be presented three different clinical vignettes illustrating outpatient clinical situations and will be asked to propose prescriptions for each vignette (number of ATs, type, dosage and duration). A computer-generated randomisation scheme implemented in the online survey will be used to allocate physicians to the experimental or control arm and then stratified by medical specialty. The primary outcome will be fully appropriate prescription of oral ATs ie, that comply with the guidelines in terms of number of drugs, drug class, dosage and duration. To demonstrate a 5% increase in this proportion, we will need to include a minimum of 230 physicians per arm. A logistic mixed model with a clinical vignette-effect and a physician-effect nested in the arm of the study will be used. ETHICS AND DISSEMINATION: The TRIAL REGISTRATION NUMBER: NCT03630874; Pre-results.

Indexed as

Decision Support TechniquesFibrinolytic AgentsAdministration, OralAdultCardiologistsDrug Therapy, CombinationFranceGeneral PractitionersHumansPractice Guidelines as TopicRandomized Controlled Trials as TopicSurveys and QuestionnairesFibrinolytic Agentsantithrombotic combinationclinical vignettesprescription support-tool

Identifiers

PMID31182442
PMCPMC6561457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.